Comparison

NMN vs NR vs Direct NAD+

Last updated 2026-07-02· Last reviewed 2026-07-02· 1 min read

Reviewed by the Ultimate Longevity Bible editorial team. Educational reference — not medical advice. See disclaimer.

Pharmacokinetics

NR: oral bioavailability is complex — much is deamidated and converted to nicotinamide before entering cells; still raises blood NAD⁺ in RCTs.
NMN: extracellular NMN is likely dephosphorylated to NR before uptake; the Slc12a8-mediated NMN transporter model is disputed.
Direct NAD⁺: doesn't cross cell membranes efficiently; likely broken down and re-synthesised. Persistent IV administration is required.

Evidence

NR RCTs: reliable blood-NAD⁺ elevation; modest signals for muscle mitochondrial function, blood pressure, and metabolic markers.
NMN RCTs: similar profile emerging; particularly explored in aged Japanese cohorts.
Direct NAD⁺ IV: mostly anecdotal / open-label; no rigorous RCT evidence.

Practical

NR: standard supplement doses 250–500 mg/day.
NMN: 250–500 mg/day; also available as sublingual/liposomal.
NAD⁺ IV therapy: administered at wellness clinics; expensive; unclear cost-benefit.

Recommendation

Reasonable to trial NR or NMN in adults over 60, particularly with declining mitochondrial-suggestive fatigue. Not a "must-take" for younger healthy adults.